LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q4 2019

Top Holdings238 positions

Checking export access…
Activity:
282.6M$608.5M7.2%——
4 qtrssince 2019-Q1
Increased
63
??SEA LTDDelisted
Bond
246.5M$527.6M6.2%——
3 qtrssince 2019-Q2
Increased
73
338.4M$482.8M5.7%——
4 qtrssince 2019-Q1
Increased
65
??MERCADOLIBRE INCDelisted
Bond
264.4M$395.3M4.7%——
2 qtrssince 2019-Q3
Decreased
0
??MONGODB INCDelisted
Bond
153.8M$311.8M3.7%———
Decreased
0
??TELADOC HEALTH INCDelisted
Bond
151M$303.8M3.6%———
Increased
59
??Splunk Inc.Delisted
Bond
201.9M$249.6M3.0%——
2 qtrssince 2019-Q3
Increased
58
??EXACT SCIENCES CORPDelisted
Bond
139.8M$202.1M2.4%——
4 qtrssince 2019-Q1
Increased
58
101.5M$197.6M2.3%——
4 qtrssince 2019-Q1
Increased
60
??TWILIO INCDelisted
Bond
120.8M$185.1M2.2%——
3 qtrssince 2019-Q2
Increased
53
??HUAZHU GROUP LTDDelisted
Bond
163.4M$183.2M2.2%——
4 qtrssince 2019-Q1
Decreased
0
??Splunk Inc.Delisted
Bond
150.2M$181M2.1%——
2 qtrssince 2019-Q3
Decreased
0
??DEXCOM INCDelisted
Bond
120.4M$178.5M2.1%——
1 qtr
New
79
??CHEGG, INC.Delisted
Bond
108.2M$164.3M1.9%——
3 qtrssince 2019-Q2
Increased
57
142.4M$161.2M1.9%——
4 qtrssince 2019-Q1
Increased
61
??TELADOC HEALTH INCDelisted
Bond
88M$153.2M1.8%———
Increased
53
144.2M$145.2M1.7%——
4 qtrssince 2019-Q1
Increased
49
??Cree, Inc.Delisted
Bond
136.2M$144.7M1.7%——
2 qtrssince 2019-Q3
Decreased
0
??INSULET CORPORATIONDelisted
Bond
63.5M$120.9M1.4%———
Increased
48
??Rapid7, Inc.Delisted
Bond
71.7M$106.9M1.3%——
2 qtrssince 2019-Q3
Increased
48
$8.4B
AUM
238
Positions
Q4 2019
Filing
HI score · 2.0/5
Quarterly 13F Value Change
+49%Q2'19$6.5B+14%Q3'19$7.4B+14%Q4'19$8.4B
Activity profile
$ moved · Q4'19
New31%Increased34%Decreased13%Exited22%
Composition
Equity vs derivatives
Equity99%Puts0%Calls0%
Holding period
Avg 1.5 quarters
<1Q31%1-4Q69%1-2Y0%2Y+0%

LINDEN ADVISORS LP manages $8.4B across 238 positions as of Q4 2019. Top holdings: MICROCHIP TECHNOLOGY INC (7.2%), SEA LTD (6.2%), MICROCHIP TECHNOLOGY INC. (5.7%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2/5.0.

Q4 2019 Summary

Active quarter - 72 new positions, 44 exits, 82 increased. No standout high-conviction moves this quarter. Portfolio: $8.4B across 238 positions.

Top holdings by portfolio weight

Total AUM$8B
MICROCHIP TE7.20%
SEA LTD6.25%
MICROCHIP TE5.72%
MERCADOLIBRE4.68%
MONGODB INC3.69%
TELADOC HEAL3.60%
Splunk Inc.2.95%
EXACT SCIENC2.39%
SAREPTA THER2.34%
TWILIO INC2.19%
Other2.17%

Portfolio allocation by GICS sector

Sectors10
Unknown71.85%
Financial Services10.73%
Industrials5.92%
Communication Services5.13%
Consumer Cyclical2.36%
Technology2.23%
Real Estate0.95%
Consumer Defensive0.56%
Healthcare0.23%
Energy0.02%

Behavioral investing profile

Checking access…
Diversified Scout
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L57
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+151.4M shares+$192.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC
Q4 2024 → Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 → Q2 2026+26.6M shares+$50.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used